NCT04044404

Brief Summary

In this study, a prospective, randomized and controlled clinical study would be carried out to establish Ultrasound Integrated Precision Diagnosis Technology with elastography as the core technology to evaluate renal injury and repair comprehensively and accurately, and to improve the clinical diagnosis chance of renal injury (or renal fibrosis). Combined with the dynamic changes of biomarkers (inflammatory factors, cytokines secreted by immune cells, etc.) after kidney injury, the research on the prognosis of kidney disease with ultrasound elastography technology as the core would be explored, which aims to provide a scientific basis for the application of Ultrasound Integrated Precision Diagnosis Technology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
208

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2019

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 29, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 1, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 5, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

November 27, 2023

Status Verified

November 1, 2023

Enrollment Period

2.1 years

First QC Date

August 1, 2019

Last Update Submit

November 23, 2023

Conditions

Keywords

Ultrasound ElastographyUltrasound Integrated Precision Diagnosis TechnologyAcute on Chronic Kidney DiseaseKidney transplantationkidney fibrosis

Outcome Measures

Primary Outcomes (3)

  • Number of patients with creatinine increasing by more than 50%

    Number of patients with creatinine increasing by more than 50% of baseline.

    1st month-12 month

  • Number of patients with initiation of continuous renal replacement therapy

    for non-transplantation patient

    1st month-12 month

  • Rate of death

    for all patients

    1st month-12 month

Secondary Outcomes (3)

  • Number of patients with cardiovascular events

    1st month-12 month

  • Number of patients with cerebrovascular events

    1st month-12 month

  • Number of patients with new serious infections requiring hospitalization

    1st month-12 month

Other Outcomes (2)

  • Number of patients with recovery of creatinine within 7 days less than 70%.

    1st month-12 month

  • Number of patients with allograft loss

    1st month-12 month

Study Arms (3)

A on C group

Acute on Chronic Kidney Disease patients

Diagnostic Test: Ultrasound Integrated Precision Diagnosis Technology(ultrasound elastography)

functional delayed graft function group

patients with functional delayed graft function(fDGF) after kidney transplantation

Diagnostic Test: Ultrasound Integrated Precision Diagnosis Technology(ultrasound elastography)

Normal

without functional kidney injury

Diagnostic Test: Ultrasound Integrated Precision Diagnosis Technology(ultrasound elastography)

Interventions

Compare the ultrasound Integrated Precision Diagnosis Technology(ultrasound elastography) with the diagnostic gold standard of kidney disease---kidney biopsy

A on C groupNormalfunctional delayed graft function group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

For A on C group:18-70 years old patient who can cooperate with breath-holding, breath-holding and breath-exhaling movements, and communicate without obstacles, signed informed consent and with abnormal renal pathology or glomerular filtration rate(GFR) (15 \<GFR\<90 ml/min.1.73 m2) or proteinuria \> 1 g/24 h due to any cause. For fDGF in kidney transplantation patient :18-65 years old patient who can cooperate with breath-holding, breath-holding and breath-exhaling movements, and communicate without obstacles, signed informed consent and received Kidney transplant recipients in our hospital from May 2019 to November 2019.

You may qualify if:

  • for A on C group 1.18-70 years old; gender is not limited; 2. Patients who can cooperate with breath-holding, breath-holding and breath-exhaling movements, and communicate without obstacles.
  • The informed consent has been signed; 4.Abnormal renal pathology or glomerular filtration rate(GFR) (15 \<GFR\<90 ml/min.1.73 m2) or proteinuria \> 1 g/24 h due to any cause.
  • for kidney transplantation
  • years old; gender is not limited;
  • It can cooperate with breath-holding, breath-holding and breath-exhaling movements, and communicate without obstacles.
  • The informed consent has been signed;
  • Kidney transplant recipients in our hospital from May 2019 to November 2019

You may not qualify if:

  • for A on C group
  • Can't cooperate, can't lie down for at least 10 minutes, unconsciousness, severe hypoxia, restlessness need to rescue patients.
  • Patients with pregnancy or cancer;
  • There are other serious diseases that the researchers do not think it is suitable to participate in this experiment.
  • Absolute contraindications of renal puncture, ① Obvious bleeding tendency; ②Severe hypertension (systolic pressure greater than 180 mm Hg or diastolic pressure greater than 115 mm Hg); ③Psychiatric patients or non-cooperating operators and isolated kidney (small kidney) Or relative contraindications of renal puncture: ① Active pyelonephritis, renal tuberculosis, hydronephrosis or pyonephrosis, ②renal abscess or perirenal abscess. ③Renal tumors or renal aneurysms. ④Polycystic kidney or renal cyst. ⑤Kidney position is too high (deep inhalation of the lower pole of the kidney is not below the twelve ribs) or migratory kidney. ⑥Obesity, severe ascites.
  • b)for kidney transplantation
  • <!-- -->
  • Can't cooperate, can't lie down for at least 10 minutes, unconsciousness, severe hypoxia, restlessness need to rescue patients.
  • Patients with pregnancy or cancer;
  • There are other serious diseases that the researchers do not think it is suitable to participate in this experiment.
  • Absolute contraindications of renal puncture, ① Obvious bleeding tendency; ②Severe hypertension (systolic pressure greater than 180 mm Hg or diastolic pressure greater than 115 mm Hg); ③Psychiatric patients or non-cooperating operators and isolated kidney (small kidney) Or relative contraindications of renal puncture: ① Active pyelonephritis, renal tuberculosis, hydronephrosis or pyonephrosis, ②renal abscess or perirenal abscess. ③Renal tumors or renal aneurysms. ④Polycystic kidney or renal cyst. ⑤Kidney position is too high (deep inhalation of the lower pole of the kidney is not below the twelve ribs) or migratory kidney. ⑥Obesity, severe ascites.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of nephrology , Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200127, China

Location

China-Japan Friendship Hospital

Beijing, China

Location

MeSH Terms

Conditions

DiseaseKidney Diseases

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2019

First Posted

August 5, 2019

Study Start

April 29, 2019

Primary Completion

May 29, 2021

Study Completion

June 30, 2021

Last Updated

November 27, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations